Azathioprine controlled releaseAlternative Names: Azathioprine-controlled release; Azathioprine-extended release
Latest Information Update: 26 Apr 2007
At a glance
- Originator Santarus
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Crohn's disease
Most Recent Events
- 08 Aug 2000 New profile
- 08 Aug 2000 Phase-II clinical trials for Crohn's disease in USA (PO)